(Q40664845)
Statements
1 reference
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients (English)
1 reference
Eric R Siemers
1 reference
Karen L Sundell
1 reference
Christopher Carlson
1 reference
Michael Case
1 reference
Gopalan Sethuraman
1 reference
Hong Liu-Seifert
1 reference
Sherie A Dowsett
1 reference
Michael J Pontecorvo
1 reference
Robert A Dean
1 reference
Ronald Demattos
1 reference
31 July 2015
1 reference
1 reference
12
1 reference
2
1 reference
110-120
1 reference
Identifiers
1 reference
1 reference